Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction

JAMA

Volumn 298, Issue 20, 2007, Pages 2399-2405

  Díaz, Rafael ^b   Goyal, Abhinav ^a,c,d   Mehta, Shamir R ^d,e   Afzal, Rizwan ^d,e   Xavier, Denis ^d,f   Pais, Prem ^f   Chrolavicius, Susan ^d,e   Zhu, Jun ^g   Kazmi, Khawar ^h   Liu, Lisheng ^g   Budaj, Andrzej ⁱ   Zubaid, Mohammad ^j   Avezum, Alvaro ^k   Ruda, Mikhail ^l   Yusuf, Salim ^d,e  

^a EMORY UNIVERSITY   (United States)

^b Etudios Cardiologica Latin America Rosario   (Argentina)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HAMILTON HEALTH SCIENCES   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^g FUWAI HOSPITAL   (China)

^h AGA KHAN UNIVERSITY   (Pakistan)

ⁱ GROCHOWSKI HOSPITAL   (Poland)

^j MUBARAK AL KABEER HOSPITAL   (Kuwait)

^k INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^l INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; POTASSIUM;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POST HOC ANALYSIS; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 36549055740     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.298.20.2399     Document Type: Article

References (13)

1. Maroko PR, Libby P, Sobel BE, et al. Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation. 1972;45(6):1160-1175.
2. Opie LH, Bruyneel K, Owen P. Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon. Circulation. 1975;52(1):49-57.
3. Dalby AJ, Bricknell OL, Opie LH. Effect of glucose-insulin-potassium infusions on epicardial ECG changes and on myocardial metabolic changes after coronary artery ligation in dogs. Cardiovasc Res. 1981;15(10):588-598.
4. Fath-Ordoubadi F, Beatt KJ. Glucose-insulinpotassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 1997;96(4):1152-1156.
5. Mehta SR, Yusuf S, Díaz R, et al; CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005;293(4):437-446.
6. Yusuf S, Mehta SR, Chrolavicius S, et al; OASIS-6 Trial Group. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA. 2006;295(13):1519-1530.
7. Yusuf S, Mehta SR, Xie C, et al; CREATE Trial Group Investigators. Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation. JAMA. 2005;293(4):427-435.
8. Yusuf S, Mehta SR, Diaz R, et al. Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: the CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction. Am Heart J. 2004;148(6):1068-1078.
9. Rackley CE, Russell RO Jr, Rogers WJ, Mantle JA, McDaniel HG, Papapietro SE. Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction. Am Heart J. 1981;102(6 pt 1):1038-1049.
10. Whitlow PL, Rogers WJ, Smith LR, et al. Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction. Am J Cardiol. 1982;49(4):811-820.
11. Rogers WJ, Stanley AW Jr, Breinig JB, et al. Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion. Am Heart J. 1976;92(4):441-454.
12. Rogers WJ, Segall PH, McDaniel HG, et al. Prospective randomized trial of glucose-insulinpotassium in acute myocardial infarction: effects on myocardial hemodynamics, substrates and rhythm. Am J Cardiol. 1979;43(4):801-809.
13. IMMEDIATE Trial. Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care Trial. http://www. clinicaltrials.gov/ct/show/NCT00091507?order=6. Accessed September 28, 2007.